We have defined structural features that are apparently important for the binding of four different, unrelated antigenic epitopes to the same major histocompatibility complex (MHC) class I molecule, H-2Kd . The four epitopes are recognized in the form of synthetic peptides by cytotoxic T lymphocytes of the appropriate specificity. By analysis of the relative potency of truncated peptides, we demonstrated that for each of the four epitopes, optimal antigenic activity was present in a peptide of 9 or 10 amino acid residues . A comparison of the relative competitor activity of the different-length peptides in a functional competition assay, as well as in a direct binding assay based on photoaffinity labeling of the Kd molecule, indicated that the enhanced potency of the peptides upon reduction in length was most likely due to a higher affinity of the shorter peptides for the Kd molecule. A remarkably simple motif that appears to be important for the specific binding of Kd-restricted peptides was identified by the analysis of peptides containing amino acid substitutions or deletions . The motif consists of two elements, a Tyr in the second position relative to the NH2 terminus and a hydrophobic residue with a large aliphatic side chain (Leu, Ile, or Val) at the COON-terminal end of the optimal 9-or 10-mer peptides. We demonstrated that a simple peptide analogue (AYP6L) that incorporates the motif can effectively and specifically interact with the Kd molecule . Moreover, all of the additional Kd-restricted epitopes defined thus far in the literature contain the motif, and it may thus be useful for the prediction of new epitopes recognized by T cells in the context of this MHC class I molecule .
We have defined structural features that are apparently important for the binding of four different, unrelated antigenic epitopes to the same major histocompatibility complex (MHC) class I molecule, H-2Kd . The four epitopes are recognized in the form of synthetic peptides by cytotoxic T lymphocytes of the appropriate specificity. By analysis of the relative potency of truncated peptides, we demonstrated that for each of the four epitopes, optimal antigenic activity was present in a peptide of 9 or 10 amino acid residues . A comparison of the relative competitor activity of the different-length peptides in a functional competition assay, as well as in a direct binding assay based on photoaffinity labeling of the Kd molecule, indicated that the enhanced potency of the peptides upon reduction in length was most likely due to a higher affinity of the shorter peptides for the Kd molecule. A remarkably simple motif that appears to be important for the specific binding of Kd-restricted peptides was identified by the analysis of peptides containing amino acid substitutions or deletions . The motif consists of two elements, a Tyr in the second position relative to the NH2 terminus and a hydrophobic residue with a large aliphatic side chain (Leu, Ile, or Val) at the COON-terminal end of the optimal 9-or 10-mer peptides. We demonstrated that a simple peptide analogue (AYP6L) that incorporates the motif can effectively and specifically interact with the Kd molecule . Moreover, all of the additional Kd-restricted epitopes defined thus far in the literature contain the motif, and it may thus be useful for the prediction of new epitopes recognized by T cells in the context of this MHC class I molecule .
T lymphocytes recognize antigen in the form of complexes with polymorphic cell surface proteins encoded by the MHC (reviewed in references 1 and 2). The two major subpopulations of T lymphocytes, CD4+ and CD8+ T cells, recognize antigen in the context of MHC class II or class I molecules, respectively. In many instances, it has been demonstrated that specific T cells can recognize antigen in the form of synthetic peptides that correspond to linear sequences of the native antigen (reviewed in references 3 and 4), provided the peptides are presented by cells expressing the appropriate MHC molecules . In recent reports, naturally processed antigens recognized by virus-specific CD8+ CTL were isolated from infected-cell extracts by chromatographic techniques. In each case the naturally occurring antigen was identified as a short peptide composed of eight or nine amino acid residues (5, 6) .
The molecular details of the binding of antigenic peptides to MHC molecules are not completely understood. From an X-ray crystallographic analysis of the HLAA2 class I MHC molecule, a region for the binding of antigenic peptides has been proposed (7, 8) . In that model, the peptide binding site consists of a groove that contains most of the polymorphic MHC residues. A similar model has been proposed for MHC class II molecules (9) . More recently, a comparison of the three-dimensional structure of HLAA2 with that of a second human MHC class I molecule, HLAAw68 (10) , revealed that the antigen binding site contains pockets shaped by polymorphic residues. It was suggested that the binding of amino acid side chains from antigenic peptides in these pockets could provide a structural basis for the allele specificity of peptide binding.
One approach for identifying structural features that confer on antigenic peptides their ability to interact with particular MHC molecules has been to compare the relative binding capacity of different peptides to purified MHC molecules . Based on the analysis of 'a series of MHC class II-restricted antigenic peptides and closely related variants, allele-specific motifs have been proposed for the MHC class II molecules, IAd and IEd, in the mouse and HLA-DR in man (11) (12) (13) . Thus far, no allele-specific motifs have been identified for MHC class I-restricted peptides .
We have developed a functional competition assay (14, 15) to analyze peptides recognized in the context of MHC class I molecules . For the antigenic peptide HLAA24 (A24) 170-182, we identified three residues (Tyrl71, Thr178, Leul79) that appear to allow the peptide to interact with the H-2Kd class I molecule (16) . We demonstrated that a peptide analogue (AYP5TLA) of the A24 peptide that incorporates the Tyr17t (Y) residue and the Thr17s-Leu179 (TL) pair of residues separated by a pentaproline spacer was an efficient competitor for at least four different K4-restricted peptides (16, 16a) .
Of the three residues in the A24 motif, Tyrl71 appeared to be the most critical for efficient competitor activity. In a recent study (16a), we noted that all of the Kd-restricted CTL epitopes that had been defined in the literature had in common the presence of at least one Tyr residue. proposed that Tyr may function as a strong "anchor" for binding peptides to the Kd molecule .
Our earlier experiments suggested that the relative position of Tyr within the antigenic peptide might also be important . For a series of homologous Kd-restricted A24 and CW3 antigenic peptides having in common a COOH terminus at position 182, the most potent peptides both as antigens and competitors were those with the Tyr1 71 residue at the second position relative to the NH2 terminus (17) . For peptide P198 -.14-24, the Tyr residue is also situated in the second position, and truncation of the NH2-terminal residue rendered the peptide 3-10-fold less active as a competitor (Maryanski, J.L., and G. Corradin, unpublished observations) . Moreover, the latter peptide (P198 -.15-24) was no longer recognized by P198-specific CTL (18) . For the influenza NP peptide NP 147-158 (and variant peptide NP 147-158 [R -156) [19) ), the Tyr residue is also located in the second position, but in this case it is not known whether a truncated NP peptide having Tyr at the NH2 terminus would retain antigenic or competitor activity. However, according to a recent report, the naturally presented NP peptide recovered from virus-infected cells appears to correspond to the sequence TYQRTRALV that contains Tyr in the second position (6) .
For the synthetic peptides that were used to define the Kd-restricted CTL epitopes of the P. berghei and P yoelii CS proteins (peptides P.h CS 249-260 and P.y. CS 277-288), the critical Tyr residues are instead located in the fifth position (20, 21) . In the present report, we have assessed whether the position of Tyr within these two homologous malaria CTL epitopes was likewise important . We found that indeed the most active CS peptides tested were 9-mer species with Tyr in the second position . The enhanced activity of the shortened CS peptides prompted us to synthesize COOH-terminally truncated versions of the A24, NP, and P198 peptides. For 'Abbreviations used in this paper: CS, circumsporozoite ; NP, nucleoprotein .
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each of these peptides, we found a shortened sequence that was considerably more potent, both as an antigen and as a competitor, than the peptides that had originally been defined .
Furthermore, a comparison of the optimal sequences for the four antigenic peptides analyzed in this study allows us to suggest the existence of a structural motif that may govern the binding of peptides to the Kd molecule and hence may be useful for the prediction of new Kd-restricted antigenic epitopes.
Materials and Methods
Cells . The isolation and characterization ofCTL clones specific for the CS protein of P. berghei (20) , of CTL clones specific for HLA-CW3 (CTIrCW3/1.1 and CTIrCW3/701 .1) or HLA-A24 (CTI,A24/10 .1) (22) , and of CTL clone P198.6 specific for antigenic mutant P198 ofthe mouse mastocytoma P815 (23) is described elsewhere. CTL clones specific for the CS protein ofP. yoelii (YA8 and YB15) were isolated from sporozoite-immune spleen cells of BALB/c mice (21) following procedures described elsewhere (20) . CTIrNP-B25 was derived from a BALB/c mouse immunized with influenza peptide NP 147-158 (Romero et al., manuscript in preparation) . The latter CTL clones are Kd restricted . CTL clone P91.6 (23) , which recognizes the P91 mutant of P815, is Ld restricted.
Peptide Synthesis and Purification . The Fmoc strategy for solid phase peptide synthesis was used as described by Merrifield (24) and by Atherton et al. (25) . HPLC-purified peptides were >90% pure by analytical HPLC. Lyophilized peptides were dissolved in 0.7% sodium bicarbonate buffer or water and further diluted in DME containing 5% FCS. Amino acid analysis confirmed the expected peptide composition.
Cytolytic Assay. P815 cells (106) were labeled with 150 /ACi sodium ("Cr) chromate, as described (26) , for 1 h at 37°C and washed three times. Labeled targets (2 x 103) in 50-Etl volumes were added to wells of V-bottomed microtiter plates containing 100-IA1 volumes of the appropriate peptide diluted in DME supplemented with 5% FCS and 10 mM Hepes. CTL (6 x 103) were added in 50-Al volumes. After a 4-h incubation at 37°C, the supernatants (100 gl) were harvested for counting. The percent lysis was calculated as: 100x [(experimental -spontaneous release)/(total -spontaneous release)] . Therelative antigenic activity ofthe peptides was calculated for the peptide concentration required to obtain 50% of the maximal lysis. For competition experiments, the target cells were incubated for 15 min with the competitor peptide (100-ul volume) before addition of a suboptimal concentration of the antigenic peptide (50-Ftl volume) . CTL (50-ELI volume) were added after a further 15-min incubation at room temperature. The plates were then incubated for 4 h at 37°C. The percent control lysis was calculated as: 100x [(percent lysis with competitorbackground lysis)/(percent lysis without competitor -background lysis)]. Background lysis represents the percent lysis of the target cells in the absence ofpeptides. The relative competitor efficiency of the peptides was calculated for the peptide concentration required to obtain 50% control lysis.
Competition Assay by Photoainity Labeling. The H-2Kd photoreactive probe (27) used in this study was ('15I)iodo-4-azido salicyloyl (IASA) YIPSAEK(Biotin)I, a derivative ofthe peptide P.b. CS 253-260. The compound YIPSAEK(Biotin)I was synthesized by reacting FmocYIPSAEKI with N-hydroxysuccinimidyl-biotin (Biotin-ONSu) in DMSO in the presence of1-hydro)xybenzotriazole. The reaction mixture was treated with piperidine and the resulting YIPSAEK(Biotin)I derivative was purified by RP-HPLC . Freshly radioiodinated IASA-ONSu (28, 29) was reacted with YIPSAEK-(Biotin)I and the (1251) IASAYIPSAEK(Biotin)I derivative was purified by RP-HPLC. All procedures involving photoreactive reagents were performed under dimmed light. For photoaffmity labeling, cells were washed two times in PBS and resuspended in DME supplemented with Hepes (20 mM), gentamycin (40 lug/ml), and FCS (0 .5%) . P815 cells (2 x 106) were incubated with the (1'sl) IASAYIPSAEK(Biotin)I photoprobe (10' cpm, sp act, 1,700-2,300 Ci/mmol) at a concentration of 3 x 10 -9 M in the absence or presence of various concentrations of competitor peptides in sixwell plates (Costar, Cambridge, MA) at 37°C. After a 5-h incubation at 37°C, the mixtures were irradiated for 10 min at 4°C with UV light (15-W lamp with a maximum emission at 312 nm ; Bioblock Scientific, Illkirch, France). The labeled cells were solubilized by adding NP-40 (0 .7%) in the presence of iodoacetamide (10 mM), PMSF (1 mM), and leupeptin (10 lug/ml) on ice. The samples were then subjected to immunoprecipitation with the antiKd mAb SFl-1.1 .1 as described (27) . The samples were analyzed by SDS-PAGE on 10% linear polyacrylamide gels under reducing conditions .
Results
Enhanced Potency ofP . yoelii and P. bergheiAntigenic Peptides ly Truncation at the NH2 Terminus. To determine the optimal length of the P. yoelii CTL epitope CS 277-288, several NH2-terminally truncated peptides were synthesized and tested for their ability to interact with the Kd molecule in an indirect functional competition assay. The 9-mer and 8-mer peptides, SYVPSAEQI and YVPSAEQI, respectively, were at least 30-fold more potent competitors than the originally defined 12-mers ( Fig . 1 and Table 1 ) . Moreover, when tested for recognition by two independent P. yoelii-specific CTL clones, the 9-mer peptide was -100-fold more active than the 12-mer, and the 8-mer was at least 10-fold more active . In contrast, the activity of the intermediate-length peptides was not significantly improved compared to the original 12-mer (Table 1) . A similar panel of P. berghei NH2-terminally truncated peptides was also prepared. As had been found for theP . yoelii "' Competitor activity for the CS P. yoelii panel of truncated peptides was assessed with CTL clone CW3/1 .1 and antigenic peptide CW3 170-182 (1 .5 x 10 -7 M for Exp. A and 10 -7 M for Exp. B) . Control lysis in the absence of competitor peptides was 43% (Exp . A) and 66% (Exp . B), and lysis in the absence of antigenicpeptide was <4% . 50% inhibition of control lysis with reference competitor peptide CS Ry. 277-288 was obtained at 1.2 x 10 -6 M for Exp. A and 5 .6 x 10-7 M for Exp. B. The competitor activity is expressed as the relative concentration of peptide required to obtain 50% inhibition of control lysis, compared to the CS Ry. 277-288 peptide. t Antigenic activity of the panel of CS P. yoelii-truncated peptides was assayed with two independent P. yoelii-specific CTL clones . For reference peptide CS Ry. 277-288, 50% maximal lysis was obtained with 1.5 x 10 -10 M for clone Y.A8, and with 8 x 10-10 M for clone Y.B15 . The antigenic activity is expressed as the relative concentration of peptide required to obtain 50% maximal lysis compared to the CS Ry. 277-288 peptide. Competitor activity of the panel of NH2-terminally truncated CS P.b . peptides was assessed with CTL clone CW3/1.1 and antigenic peptide CW3 170-182 (10 -7 M) . Control lysis in the absence of competitor was 84% and lysis in the absence of antigenic peptide was 10% . 50% inhibition of control lysis with reference competitor peptide CS PA 249-260 was obtained at 2 x 10 -5 M. 5 Competitor activity of the panel of COOH-terminally truncated CS P.b . peptides was assessed with CTL clone CW3/1.1 and antigenic peptide CW3 170-182 (1 .5 x 10-7 M) . Control lysis in the absence of competitor peptide was 66% and lysis in the absence of antigenic peptide was 12% . 50% inhibition of control lysis with reference competitor peptide CS PA 249-260 was obtained at 1 . sequence, both the 9-mer (SYIPSAEKI) and 8-mer (YIP-SAEKI) P. berghei peptides displayed a considerably higher competitor activity than the original 12-mer (Table 2) . In this case, the increase in potency was at least 40-fold for both
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H-2Kd Binding Motif peptides. In terms of recognition, the relative activity o£ the different length P. berghei peptides was similar to the relative competitor activity. However, for CTL clone CS.C1, the increase in antigenic activity of the 8-mer peptide YIPSAEKI Table 2) . No Further Improvement in Potency of the Highly Active Peptide P. berghei CS 252-260 by Extension orDeletion at the COOH Terminus. The activity of the highly efficient 9-mer peptide h lx CS 252-260 (SYIPSAEKI) could not be improved by adding or deleting one or two residues at the COOH terminus. In fact, as shown in Table 2 , the 11-mer peptide SYIP-SAEKILE was at least fivefold less active both as an antigen and as a competitor than the 9-mer, and the activity of the 10-mer, SYIPSAEKIL, was decreased by several-fold. Moreover, deletion of the COOH-terminal residue Ilez 6o resulted in a 100-fold reduction in competitor activity and the peptide was no longer recognized by the CTL clones tested ( Table  2 , and data not shown) . A similar reduction in activity was observed for the shortest of the peptides tested, SYIPSAE ( Table 2) .
The Highly Active 9-mer Malaria Antigenic Peptides Are Also Potent Competitors for a Kd-speck Photoprobe. We have recently demonstrated that photoreactive derivatives of the P. berghei CTL epitope bind specifically to the Kd molecule in living cells (27) . Moreover, binding of the radiolabeled photoprobe, IASAYIPSAEK(Biotin)I, to the Kd molecule could be inhibited by different peptides known to be presented by Kd , but not by peptides presented by other class I MHC molecules . It was thus possible to compare the competitor activity of the different length malaria peptides in this direct peptide binding assay. In this experiment, P815 cells (H-2d) were incubated with the 12-mer or 9-mer peptides corresponding to the P. berghei (NDDSYIPSAEKI and SYIPSAEKI) or P. yoelii (NEDSYVPSAEQI and SYVPSAEQI) sequences and the radiolabeled photoprobe at various molar ratios. As shown in Fig. 2 , both 9-mer peptides inhibited the photoaffinity labeling of the Kd molecule at -100-fold lower concentrations than did the corresponding 12-mers . These results are thus in agreement with those obtained in functional competition experiments.
Other Kd-restricted Antigenic Peptides with Tyr Residues in the Second Position Also Become More Potent Antigens and Competitors upon Truncation at the COOH Terminus. The significant increase in antigenic and competitor activity for the malaria CTL epitopes upon truncation prompted us to ask whether a similar improvement would be observed for other K'-restricted antigenic peptides. For this analysis, we chose the previously defined epitopes HLAA24170-182, influenza NP 147-158, and P198-.14-24 . For the reasons outlined in the introduction, the peptide Tyr residues were kept in the second position, and the sequences were truncated at the 000H-terminal ends .
As shown in Table 3 , truncated peptides that showed a
Competitor activity for antigenic peptide CS PA 252-260 (10-1°M) was assayed with CTL clone CS .B28 . The percent specific lysis in the absence of competitor was 79%. Percent lysis in the absence of antigenic peptide was 0% . 50% inhibition of lysis for reference A24 peptide, A24 170-182, as a competitor was obtained at 3.5 x 10 -6 M, and that for reference NP peptide, NP 147-158, was obtained at 5 x 10 -6 M. t Competitor activity for antigenic peptide CW3 170-182 (3 x 10 -s M) was assayed with CTL clone CW3/701.1 . The percent specific lysis in the absence of competitor was 79% and percent lysis in the absence of antigenic peptide was 4% . 50% inhibition of lysis for reference A24 peptide, A24 170-182, as a competitor was obtained at 5 x 10 -7 M, and that for reference NP peptide, NP 147-158, was obtained at 6 x 10 -7 M. 5 Competitor activity for antigenic peptides CS P.b. 252-260 (10 -1°M) and CW3 170-182 (3 x 10-s M) was assayed with CTL clones CS .B28 and CW3/701.1, respectively . The percent specific lysis in the absence of competitor was 66% for CTL CS .B28 and 82% for CTL CW3/701 .1 . Lysis in the absence of antigenic peptides was 3% and 7%, respectively . 50% inhibition of lysis for reference peptide P198 -.14-24 as competitor was obtained at 8 x 10-s M for CTL CS .B28, and at 8. significant increase in competitor activity were found for each antigenic system . The HLA-A24 peptide A24 170-179 was 80 >30-fold more active than the previously described peptide A24 170-182 . Similarly, the influenza peptide NP 147-155 was >40-fold more active than the longer peptide NP 147-60 158, and peptide P198 -.14-22 was 5-10-fold more active than the original 11-mer. Moreover, the most active truncated peptides in terms of competitor activity were likewise 40 the most potent as antigens for CTL clones of the appropriate specificity (Fig. 3) .
A Peptide Analogue that Incorporates the Tyr.. .Leu Motifand 20 a Pro6 Spacer Is a Potent Competitor for Kd-restricted Peptides . In a previous study, we demonstrated that the peptide analogue AYP5TLA that contains the HLAA24 residues Tyr171, 0 Thr178, and Leu179, which were identified as possible contact residues for the Kd molecule, could function as an efficient competitor for Kd-restricted antigenic peptides (16) . A 80 comparison of the truncated peptides found to be optimal T as antigens and competitors in this study suggested that im-N portant common features might be the presence of Tyr in c) 60 the second position and the residues Leu, Ile, or Val at the COOH terminus (Table 3) . We therefore analyzed a new, U w simplified series of polyproline analogues containing Tyr and a to 40
Leu residues separated by a variable number of Pro residues. The peptides were synthesized as pairs, with either Tyr or z W Ala Tyr residues at the NH2 terminus.
U cc 20 Of this series, the most efficient competitor for Kd-LL a restricted antigenic peptides was peptide AYP6L (Table 4) . The activity of the AYP6L analogue compares favorably 0 with that of two different Kd-restricted peptides, A24 170-179 and P198 -.14-22, that contain the "Tyr. ..Leu" motif, and with the previously described analogue AYP5TLA s (Table 4 ). The nearly identical analogues with P7 or P5 spacers, AYP7L and AYP5L, were less active than the AYP6L analogue by five fold and 170-fold, respectively. Analogues 6 with P4 spacers, YP4L and AYP4L, were completely inactive in this system (data not shown) . For each pair of peptides containing a P5, P6, or P7 spacer, the peptide with the Ala-40 Tyr NH2 terminus was at least 20-fold more active than its counterpart with only Tyr. A very different pattern of activity was observed when the same series of analogues was 20 tested in a competition assay with an Ld-restricted CTL clone. In this case, none of the analogues was found to be an efficient competitor (Table 4) . The analogue for which at least a low level competitor activity could be measured in the Ld-restricted system, peptide YP7L, was N30-fold less potent than the Ld-restricted reference peptide, pp89 168-176 . Moreover, in contrast to the Kd system, the analogue Figure   AYP7L with an additional NH2-terminal Ala residue was peptides.
less potent than its counterpart without Ala . (Kd-restricted) and P91 .6 (Ld-restricted), respectively. 50% inhibition of lysis for reference peptide AYP5TLA (in the experiment with CTL-CS-B28) as a competitor was obtained at 2.6 x 10 -8 M, and that for reference peptide pp89 168-176 (in the experiment with CTL-P91.6) was obtained at 3.5 x 10 -7 M. The percent specific lysis in the absence of competitor was 61% for CTL-CS .B28 and 76% for CTL-P91.6 . Lysis in the absence of antigenic peptides was <4% .
molecules probably contain a single peptide binding site (15, (30) (31) (32) (33) (34) . In that case, peptides that interact with the same MHC molecules might be expected to share structural features that allow binding to the same ligand (11) (12) (13) . Our study identifies a simple motif for Kd-restricted epitopes and also suggests that optimal Kd-binding peptides are relatively short.
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Our experiments document the marked increase in potency for four Kd-restricted, but otherwise unrelated, CTL epitopes upon reduction in their length to 9 or 10 amino acid residues . The increased potency of the shortened peptides was apparent for their activity as antigens, in CTL recognition assays, and as competitors in functional competition experiments. To assess peptide/MHC binding more directly, we * Antigen from which the CTL epitope sequence has been defined. All listed antigenic peptides can be recognized by Kd-restricted CTL with the possible exception of the peptide pp89 168-176, which has been described as an Ld-restricted epitope (35) , but that is also a potent Kd competitor (16a), and the two peptide analogues which were designed by us as Kd competitors. $ The residues corresponding to the putative Kd binding motif are underlined . have recently developed an assay based on photoaffinity labeling (27) . In this assay, a photoreactive derivative of the H-2 Kdrestricted peptide P. berghei CS 253-260 specifically labels Kd molecules on living cells . We now show that the 9-mer P. berghei and P. yoehi peptides (SYIPSAEKI and SYVPSAEQI) inhibit the photoaffinity labeling more efficiently than the corresponding 12-mers. These results strongly suggest that the increased competitor activity of the shorter peptides is indeed due to their higher affinity for the H-2 Kd molecule. Moreover, the parallel increases in antigenic and competitor activities upon truncation indicates that the different length peptides present similar epitopes to the TCR . Our observation that the nonamer NP sequence TYQR TRAW is the optimal antigenic peptide is in agreement with a recent report (6) on the characterization of the naturally processed NP peptide. Interestingly, the naturally processed antigens corresponding to a Kb-restricted epitope from vesicular stomatitis virus or to a Db-restricted epitope from the influenza NP, were also found to be short peptides of eight or nine amino acid residues, respectively (5, 6) . Moreover, truncation analysis of peptides corresponding to an Ldrestricted epitope from the mouse cytomegalovirus identified a 9-mer as the optimal antigenic peptide (35) . It is tempting to speculate that the optimal length for class I-restricted epitopes, either in synthetic or natural form, will generally be 8-10 residues.
Comparison of the short (9-mer and 10-mer) peptides that were found to be optimal antigens in the present study suggests that they share a simple structural motif that allows binding to the Kd molecule. The motif is characterized by a Tyr residue in the second position from the NH? terminus, and a hydrophobic residue (Leu, Ile, or Val) at the COON terminus (position 9 or 10) . The latter three amino acids possess large aliphatic nonpolar side chains, and were found to be grouped together in an analysis of the frequencies of amino acid changes among homologous proteins of different species (36) . Likewise, Tyr and Phe are included in another exchange group. In this context, we now have evidence that for all four Kd-restricted epitopes analyzed in this study, the Tyr residue can be replaced with Phe without a major loss of antigenic or competitor activity (our unpublished observations) . One might then predict the occurrence of other Kd-restricted epitopes in which the Tyr residue of the motif would be replaced by Phe .
The actual involvement of the motif in Kd-binding activity is clearly supported by several lines of experimental evidence . Our earlier results analyzing four unrelated Kdrestricted antigenic peptides demonstrated that the Tyr residue was indeed critical for optimal interaction with Kd in that substitution of Tyr with Ala residues resulted in at least a 50-fold reduction in competitor activity (16, 16a) . The inclusion of a COON-terminal hydrophobic residue in the Kdbinding motif was suggested in part by truncation experiments, but its functional importance was demonstrated more directly by amino acid substitution . For instance, the activity of the 8-mer peptide P.h CS 253-260 (YIPSAEKI) and of the 11-mer peptide P198 -.14-24 (KYQAVTTTLEE) was decreased by at least 100-fold and 10-fold, respectively, upon Ala substitution of the CS residue Ile26o (Romero et al ., manuscript in preparation) and the P198 residue Leu22 (16a) . Similarly, analysis of HLAA24 170-182 synthetic peptides containing single amino acid substitutions indicated that Leu179, which is the COOH-terminal residue of the optimal 10-mer peptide, was important for competitor activity (16) . In that analysis substitution of Thr17s also reduced competitor activity, indicating that in this case Thr178 may also form part of the Kd-binding motif.
Evidence for the importance of the Kd motif comes so far from experiments showing the loss of activity of peptides upon deletion or substitution . We have also developed a more positive approach to demonstrate the function of the motif. This involves the incorporation of the motif in a completely different molecular context . The peptide analogue AYP6L, which contains the simple Kd motif "Tyr. . .Leu", was found in this study to be a highly active competitor. Its activity was over fivefold higher than the competitor activity of a similar analogue, AYP5TLA, which contains the presumed Kd-binding residues (Y. . . L) of the HLA-A24 peptide (16) . The activity of both analogues appears to be allele specific and, interestingly, deletion of the NH2-terminal Ala within the analogues resulted in at least a 20-fold reduction in Kd competitor activity (16 and Table 4 ).
An analysis of the sequences of each of the Kd-restricted CTL epitopes reported to date reveals that the motif is contained within all of them (Table 5) . Moreover, in a recent study (16a), we found that the Ld-restricted antigenic peptide pp89 167-176 from a mouse cytomegalovirus (MCMV) protein (35) , competes not only with Ld-restricted peptides but also with Kd-restricted peptides. This MCMV peptide (MYPHFMPTNL) also contains the proposed Kd binding motif. The occurrence of a common motif suggests that Kd-restricted peptides might bind in a similar manner to the MHC molecule . A model for the three-dimensional structure of the Kd molecule (16a) was recently developed based on the atomic coordinates of the HLA-A2 crystal structure (7) . Two pronounced cavities were apparent in the region of the Kd model corresponding to the putative antigenbinding site. These two Kd "pockets" could well accommodate the two Kd motif residues (Tyr and hydrophobic residues like Leu, Ile, or Val) and thus provide a structural correlate for the motif.
